Vegandale
London and Manchester are gearing up for Vegandale, the unparalleled vegan experience featuring prominent artists, immersive art and 120+ global vendors
LONDON, UK / ACCESSWIRE / March 7, 2024 / Vegandale, the largest vegan experience in North America is expanding its reach to the UK with the addition of three new cities to its 2024 tour. Previously acclaimed in New York, Los Angeles, Chicago, Toronto, Miami and Dallas, the event is now extending to London, Manchester and Philadelphia, making it a nine-city annual tour. With a mission to achieve World Vegan Domination, the event annually attracts 100,000 attendees, 1000+ vendors and features live performances.
One of Vegandale's standout features is the musical component, which has quickly become a major highlight. Anticipation is growing as Vegandale prepares to announce this year's headline acts after setting the bar high in 2023 with sold out performances by Rick Ross, Coi Leray and DJ Khaled. London artists are expected to be announced by mid April.
What Vegandale (albeit proudly) lacks in omnivorous options is rectified by a diverse and growing list of food, beverage and lifestyle vendors from around the world, promising attendees an unparalleled opportunity to try the best and newest in vegan products. In particular, the London and Manchester editions are set to showcase both local and vendors from North America, offering a rare opportunity for attendees to try dishes and products not readily available elsewhere.
Adding to its virality are the festival's renowned interactive art installations, which serve as a vehicle for the festival's core ethics. With its unique blend of music, food, and art, Vegandale offers an experience unlike any other.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.The London event will be held at Clapham Common* on Saturday, July 13th and Sunday, July 14th. Tickets can be purchased from vegandalefest.com
The Manchester event will take place on Saturday, July 6th. Location TBA, tickets to launch soon.
Fans are encouraged to follow @vegandale on Instagram for more upcoming announcements.
ABOUT VEGANDALE
Vegandale, established in Toronto in 2015, is the world's largest touring vegan experience, uniting major artists, food, music and art for an unparalleled experience. With an annual tour spanning nine cities across North America and the UK, Vegandale's mission goes beyond entertainment, aiming to demonstrate the moral imperative of a world free from animal exploitation. Often compared to Coachella, this unique experience draws over 100,000 attendees annually, both vegans and non-vegans alike, with headline performances by artists like Rick Ross, Coi Leray and DJ Khaled. It serves as a cultural phenomenon, attracting global vendors and sponsors eager to showcase the latest in vegan product innovation.
*Event location is pending final park and permitting approval
Contact:
Jenna Owen
Jenna@vegandale.com
SOURCE: Vegandale
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress
Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI8.1.2026 08:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new product concepts faster than ever before. United by a joint agentic AI framework, this collaboration brings together advanced AI capabilities from both companies, marking a pivotal shift in how organizations execute insights-driven innovation. Through AI-to-AI integrations, linking two powerful AI platforms, enterprises can now enrich their product innovation process with a comprehensive data ecosystem. Specially trained DeepSights AI agents within Market Logic's Innovation Studio continuously monitor, analyse, and synthesize market research, news, and operational data-allowing for accelerated concept generation and more informed decision-making. With just a couple of clicks, customers can seamlessly progress to testing their concepts with real people, thanks to Zappi's real-world respondent solut
RE Royalties Announces up to a USD $9.0 Million Portfolio-Level Royalty Investment with Solaris Energy Inc.7.1.2026 22:20:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / RE Royalties Ltd. (TSXV:RE)(OTCQX:RROYF) ("RE Royalties" or the "Company") is pleased to announce that it has entered into a definitive agreement with Solaris Energy Inc. ("Solaris") to invest up to USD $9.0 million to acquire a royalty interest (the "Royalty Purchase") in two portfolios of distributed generation ("DG") solar projects located throughout the United States. The first portfolio consists of 15 projects including 9 under construction with several nearing operation, and 6 in development, located across California, Maine, Delaware, New Hampshire and Colorado ("Portfolio 1"). The second portfolio comprises 9 more projects, the final composition of which may evolve as the projects advance ("Portfolio 2"). The transaction represents the acquisition of a portfolio level royalty on a diversified portfolio of DG solar assets and marks the exciting beginning of a new partnership between the two parties. The Royalty Purchase for Por
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom